Trends and outcomes of venous thromboembolism in adult hospitalizations with acute myeloid leukemia: analysis of nationwide inpatient sample from 2010 to 2014

References

• Falanga A, Rickles F. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost. 2008;25:173–182.
   Web of Science ®Google Scholar
• Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using medicare claims data. Medicine (Baltimore). 1999;78:285–291.
   PubMed Web of Science ®Google Scholar
• Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. Arch Internal Med. 2002;162:1245.
   PubMed Web of Science ®Google Scholar
• Breccia M, Avvisati G, Latagliata R, et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia. 2006;21:79–83.
   PubMed Web of Science ®Google Scholar
• Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Internal Med. 2006;166:458.
   PubMed Web of Science ®Google Scholar
• Ku GH, White RH, Chew HK, et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009;113:3911–3917.
   PubMed Web of Science ®Google Scholar
• Rodriguez AO, Wun T, Chew H, et al. Venous thromboembolism in ovarian cancer. Gynecol Oncol. 2007;105:784–790.
   PubMed Web of Science ®Google Scholar
• Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost. 2001;27:593–604.
   PubMed Web of Science ®Google Scholar
• Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J clin oncol. 2009;27:4848–4857.
   PubMed Web of Science ®Google Scholar
• Vu K, Luong NV, Hubbard J, et al. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of TexasAnderson Cancer Center. Cancer Med. 2014;4:27–35.
   PubMed Web of Science ®Google Scholar
• Wu -Y-Y, Tang L, Wang M-H. Leukemia and risk of venous thromboembolism: a meta-analysis and systematic review of 144 studies comprising 162,126 patients. Sci Rep. 2017;7. DOI:10.1038/s41598-017-01307-0.
   Web of Science ®Google Scholar
• De Stefano V, SorÀ F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005;3:1985–1992.
   PubMed Web of Science ®Google Scholar
• Min W-S, Shin S-H, Yoon J-H, et al. Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thromb Haemost. 2017;113:201–208.
   Web of Science ®Google Scholar
• Sørensen HT, Mellemkjær L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–1850.
   PubMed Web of Science ®Google Scholar
• Lee AYY, Peterson EA. Treatment of cancer-associated thrombosis. Blood. 2013;122:2310–2317.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382:1599–1607.
   PubMed Web of Science ®Google Scholar
• Aujesky D, Roy P-M, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378:41–48.
   PubMed Web of Science ®Google Scholar
• Erkens PMG, Gandara E, Wells P, et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost. 2010;8:2412–2417.
   PubMed Web of Science ®Google Scholar
• Jiménez D. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Internal Med. 2010;170:1383.
   PubMed Web of Science ®Google Scholar
• Ahrari A, Al-Ani F, Wang YP, et al. Treatment of venous thromboembolism in acute leukemia: A systematic review. Thromb Res. 2019;178:1–6.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Overview of the National (Nationwide) Inpatient Sample (NIS). [cited 2020 Mar 31]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp
   Google Scholar
• Healthcare cost and utilization Project (HCUP). NIS database documentation. [cited 2020 Mar 31]. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp
   Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Trend weights for HCUP NIS data. [cited 2020 Sept 7]. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp
   Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Healthcare cost and utilization project data use agreement course. [cited 2020 Mar 25]. Available from: https://www.hcup-us.ahrq.gov/DUA/dua_508/DUA508version.jsp
   Google Scholar
• Fang MC, Fan D, Sung SH, et al. Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism. Med Care. 2017;55:e137–e143.
   PubMed Web of Science ®Google Scholar
• Del Prete C, Kim T, Lansigan F, et al. The epidemiology and clinical associations of stroke in patients with acute myeloid leukemia: a review of 10,972 admissions from the 2012 national inpatient sample. Clin Lymphoma Myeloma Leukemia. 2018;18:74–77.e71.
   PubMed Web of Science ®Google Scholar
• Bakalov V, Tang A, Yellala A, et al. Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the national inpatient sample, 2011–2015. Leuk Lymphoma. 2019;61:370–376.
   PubMed Web of Science ®Google Scholar
• Healthcare cost and utilization Project (HCUP). Elixhauser comorbidity software, Version 3.7. [cited 2020 Sept 7]. Availabe from: https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp
   Google Scholar
• Alcalay A, Wun T, Khatri V, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J clin oncol. 2006;24:1112–1118.
   PubMed Web of Science ®Google Scholar
• Petterson TM, Marks RS, Ashrani AA, et al. Risk of site-specific cancer in incident venous thromboembolism: A population-based study. Thromb Res. 2015;135:472–478.
   PubMed Web of Science ®Google Scholar
• Lee E-J, Smith BD, Merrey JW, et al. Patterns of venous thromboembolism prophylaxis during treatment of acute leukemia: results of a North American web-based survey. Clin Lymphoma Myeloma Leukemia. 2015;15:766–770.e764.
   PubMed Web of Science ®Google Scholar
• Francis CW. Prevention of venous thromboembolism in hospitalized patients with cancer. J clin oncol. 2009;27:4874–4880.
   PubMed Web of Science ®Google Scholar
• Hao T, Li-Talley M, Buck A, et al. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019;9. DOI:10.1038/s41598-019-48445-1.
   Web of Science ®Google Scholar
• Kayser S, Döhner K, Krauter J, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011;117:2137–2145.
   PubMed Web of Science ®Google Scholar
• McNerney ME, Godley LA, Le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 2017;17:513–527.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–2302.
   PubMed Web of Science ®Google Scholar
• Libourel EJ, Klerk CPW, van Norden Y, et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood. 2016;128:1854–1861.
   PubMed Web of Science ®Google Scholar
• Napolitano M, Valore L, Malato A, et al. Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study. Leuk Lymphoma. 2015;57:116–119.
   PubMed Web of Science ®Google Scholar
• Ay C, Beyer-Westendorf J, Pabinger I. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants. Ann Oncol. 2019;30:897–907.
   PubMed Web of Science ®Google Scholar
• Gangaraju R, Bhatia S, Kenzik K. Venous-thromboembolism in elderly patients with acute myeloid leukemia. Blood. 2019;134:4679.
   Web of Science ®Google Scholar
• Loh KP, Kansagra A, Shieh M-S, et al. Predictors of in-hospital mortality in patients with metastatic cancer receiving specific critical care therapies. J National Compr Cancer Network. 2016;14:979–987.
   PubMed Web of Science ®Google Scholar
• Tawfik B, Pardee TS, Isom S, et al. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML). J Geriatr Oncol. 2016;7:24–31.
   PubMed Web of Science ®Google Scholar